XML 129 R108.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

Concentrations of Risk (Details) - manufacturer	12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2022
Concentration Risk [Line Items]
Number of third-party manufacturers	122
Sales | Product concentration risk | Top 5 brands
Concentration Risk [Line Items]
Concentration risk, percentage	37.90%	38.70%	41.30%
Sales | Customer concentration risk | Walmart
Concentration Risk [Line Items]
Concentration risk, percentage	19.70%	19.70%	20.50%
Sales | Customer concentration risk | Amazon
Concentration Risk [Line Items]
Concentration risk, percentage	10.90%
Sales | Supplier concentration risk
Concentration Risk [Line Items]
Number of third-party manufacturers with long-term contracts	26	25
Sales | Supplier concentration risk | Manufacturing Facility, Lynchburg, Virginia
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%
Sales | Supplier concentration risk | Manufacturers
Concentration Risk [Line Items]
Concentration risk, percentage	72.00%	69.80%
Sales | Supplier concentration risk | Contract Pharmacal Corporation
Concentration Risk [Line Items]
Concentration risk, percentage	20.00%	20.00%	20.00%
Accounts receivable | Customer concentration risk | Walmart
Concentration Risk [Line Items]
Concentration risk, percentage	19.20%
Accounts receivable | Customer concentration risk | Amazon
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%

X

- Definition

Number of Third-party Manufacturers

+ References

No definition available.

+ Details

Name:	pbh_NumberOfThirdPartyManufacturers
Namespace Prefix:	pbh_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

X

- Definition

Number of Third-party Manufacturers with Long-term Contracts

+ References

No definition available.

+ Details

Name:	pbh_NumberOfThirdPartyManufacturersWithLongTermContracts
Namespace Prefix:	pbh_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 954
-SubTopic 310
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481027/954-310-50-2

+ Details

Name:	us-gaap_ConcentrationRiskLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482810/280-10-50-42

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-21

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482907/825-10-50-20

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482861/275-10-50-18

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482861/275-10-50-20

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=pbh_Top5BrandsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=pbh_WalmartMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_MajorCustomersAxis=pbh_AmazonMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=pbh_ManufacturingFacilityLynchburgVirginiaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=pbh_ManufacturersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_ProductOrServiceAxis=pbh_ContractPharmacalCorporationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: